Cargando…
Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma
PURPOSE: We assessed and compared clinical effects and safety endpoints of three methods of transarterial chemoembolization (TACE), conventional (cTACE), with drug-eluting beads (DEB-TACE), and with degradable starch microspheres (DSM-TACE), used in patients with hepatocellular carcinoma (HCC) in th...
Autores principales: | Mohr, Isabelle, Vogeler, Marie, Pfeiffenberger, Jan, Sprengel, Simon David, Klauss, Miriam, Radeleff, Boris, Teufel, Andreas, Chang, De-Hua, Springfeld, Christoph, Longerich, Thomas, Merle, Uta, Mehrabi, Arianeb, Weiss, Karl Heinz, Mieth, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508038/ https://www.ncbi.nlm.nih.gov/pubmed/35076764 http://dx.doi.org/10.1007/s00432-021-03900-3 |
Ejemplares similares
-
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
por: Vogeler, Marie, et al.
Publicado: (2020) -
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
por: Wehling, Cyrill, et al.
Publicado: (2021) -
Surgical management of primary liver cancers during the COVID-19 pandemic: overcoming the dilemma with standardization
por: Ramouz, Ali, et al.
Publicado: (2023) -
SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study
por: Rauber, Conrad, et al.
Publicado: (2021) -
Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular Carcinoma
por: Lozanovski, Vladimir J., et al.
Publicado: (2019)